# Feraccru® Real World Effectiveness Study in Hospital Practice ( FRESH )

> **NCT03247816** · — · COMPLETED · sponsor: **Shield Therapeutics** · enrollment: 59 (actual)

## Conditions studied

- Anemia, Iron Deficiency
- Inflammatory Bowel Diseases

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03247816
- **Lead sponsor:** Shield Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-08-14
- **Primary completion:** 2018-03-01
- **Final completion:** 2018-10-01
- **Target enrollment:** 59 (ACTUAL)
- **Last updated:** 2020-10-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03247816

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03247816, "Feraccru® Real World Effectiveness Study in Hospital Practice ( FRESH )". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03247816. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*